Obesity and cancer mechanisms: Tumor microenvironment and inflammation

Journal of Clinical Oncology

Volumn 34, Issue 35, 2016, Pages 4270-4276

  Iyengar, Neil M ^a,b   Gucalp, Ayca ^a,b   Dannenberg, Andrew J ^b   Hudis, Clifford A ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE; TUMOR MARKER;

ADIPOCYTE; ARTICLE; BODY MASS; BREAST CANCER; CANCER PROGNOSIS; CARCINOGENESIS; CELL DEATH; CELL INFILTRATION; DISEASE ASSOCIATION; DYSLIPIDEMIA; ENDOPLASMIC RETICULUM STRESS; EXTRACELLULAR MATRIX; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; INSULIN RESISTANCE; METABOLIC SYNDROME X; MICROBIOME; OBESITY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TONGUE CANCER; TUMOR GROWTH; TUMOR MICROENVIRONMENT; WHITE ADIPOSE TISSUE; COMPLICATION; DISEASE COURSE; NEOPLASM; PATHOPHYSIOLOGY; RISK FACTOR;

BIOMARKERS, TUMOR; DISEASE PROGRESSION; HUMANS; INFLAMMATION; NEOPLASMS; OBESITY; RISK FACTORS; TUMOR MICROENVIRONMENT;

EID: 85002854064     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2016.67.4283     Document Type: Article

References (70)

1. Balkwill F, Charles KA, Mantovani A: Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7:211-217, 2005
2. Mantovani A, Allavena P, Sica A, et al: Cancerrelated inflammation. Nature 454:436-444, 2008
3. Coussens LM, Werb Z: Inflammation and cancer. Nature 420:860-867, 2002
4. Ernst PB, Gold BD: The disease spectrum of Helicobacter pylori: The immunopathogenesis of gastroduodenal ulcer and gastric cancer. Annu Rev Microbiol 54:615-640, 2000
5. Zur Hausen H: Papillomaviruses and cancer: From basic studies to clinical application. Nat Rev Cancer 2:342-350, 2002
6. Tsukuma H, Hiyama T, Tanaka S, et al: Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 328:1797-1801, 1993
7. Takahashi H, Ogata H, Nishigaki R, et al: Tobacco smoke promotes lung tumorigenesis by triggering IKKbeta- and JNK1-dependent inflammation. Cancer Cell 17:89-97, 2010
8. Garro AJ, Lieber CS: Alcohol and cancer. Annu Rev Pharmacol Toxicol 30:219-249, 1990
9. Olefsky JM, Glass CK: Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 72:219-246, 2010
10. Iyengar NM, Hudis CA, Dannenberg AJ: Obesity and cancer: Local and systemic mechanisms. Annu Rev Med 66:297-309, 2015
11. Flegal KM, Carroll MD, Ogden CL, et al: Prevalence and trends in obesity among US adults, 1999-2008. JAMA 303:235-241, 2010
12. Levi J, Segal LM, St. Laurent R, et al: F as in fat: How obesity threatens America's future 2012. http://healthyamericans.org/assets/files/TFAH2012FasInFatFnlRv.pdf
13. Sinicrope FA, Dannenberg AJ: Obesity and breast cancer prognosis: Weight of the evidence. J Clin Oncol 29:4-7, 2011
14. Howe LR, Subbaramaiah K, Hudis CA, et al: Molecular pathways: Adipose inflammation as a mediator of obesity-associated cancer. Clin Cancer Res 19:6074-6083, 2013
15. Rosen ED, Spiegelman BM: What we talk about when we talk about fat. Cell 156:20-44, 2014
16. Van Kruijsdijk RC, Van Der Wall E, Visseren FL: Obesity and cancer: The role of dysfunctional adipose tissue. Cancer Epidemiol Biomarkers Prev 18:2569-2578, 2009
17. Deepa M, Papita M, Nazir A, et al: Lean people with dysglycemia have a worse metabolic profile than centrally obese people without dysglycemia. Diabetes Technol Ther 16:91-96, 2014
18. Chen S, Chen Y, Liu X, et al: Insulin resistance and metabolic syndrome in normal-weight individuals. Endocrine 46:496-504, 2014
19. Iyengar NM, Morris PG, Zhou XK, et al: Menopause is a determinant of breast adipose inflammation. Cancer Prev Res (Phila) 8:349-358, 2015
20. Xu XJ, Gauthier MS, Hess DT, et al: Insulin sensitive and resistant obesity in humans: AMPK activity, oxidative stress, and depot-specific changes in gene expression in adipose tissue. J Lipid Res 53:792-801, 2012
21. Denis GV, Obin MS: 'Metabolically healthy obesity': Origins and implications. Mol Aspects Med 34:59-70, 2013
22. Klöting N, Fasshauer M, Dietrich A, et al: Insulin-sensitive obesity. Am J Physiol Endocrinol Metab 299:E506-E515, 2010
23. Sahakyan KR, Somers VK, Rodriguez-Escudero JP, et al: Normal-weight central obesity: Implications for total and cardiovascular mortality. Ann Intern Med 163:827-835, 2015
24. Poirier P: The many paradoxes of our modern world: Is there really an obesity paradox or is it only a matter of adiposity assessment? Ann Intern Med 163:880-881, 2015
25. De Visser KE, Eichten A, Coussens LM: Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 6:24-37, 2006
26. Monteiro R, Azevedo I: Chronic inflammation in obesity and the metabolic syndrome. Mediators Inflamm 10.1155/2010/289645 [epub ahead of print on July 14, 2010]
27. Amano SU, Cohen JL, Vangala P, et al: Local proliferation of macrophages contributes to obesityassociated adipose tissue inflammation. Cell Metab 19:162-171, 2014
28. Cinti S, Mitchell G, Barbatelli G, et al: Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 46:2347-2355, 2005
29. Shapiro H, Pecht T, Shaco-Levy R, et al: Adipose tissue foam cells are present in human obesity. J Clin Endocrinol Metab 98:1173-1181, 2013
30. Lee JY, Sohn KH, Rhee SH, et al: Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through toll-like receptor 4. J Biol Chem 276:16683-16689, 2001
31. Subbaramaiah K, Howe LR, Bhardwaj P, et al: Obesity is associatedwith inflammation and elevated aromatase expression in themousemammary gland. Cancer Prev Res (Phila) 4:329-346, 2011
32. Morris PG, Hudis CA, Giri D, et al: Inflammation and increased aromatase expression occur in the breast tissue of obese women with breast cancer. Cancer Prev Res (Phila) 4:1021-1029, 2011
33. Sun X, Casbas-Hernandez P, Bigelow C, et al: Normal breast tissue of obese women is enriched for macrophage markers and macrophage-associated gene expression. Breast Cancer Res Treat 131:1003-1012, 2012
34. Iyengar NM, Zhou XK, Gucalp A, et al: Systemic correlates of white adipose tissue inflammation in early-stage breast cancer. Clin Cancer Res 22:2283-2289, 2016
35. Koru-Sengul T, Santander AM, Miao F, et al: Breast cancers from black women exhibit higher numbers of immunosuppressive macrophages with proliferative activity and of crown-like structures associated with lower survival compared to non-black Latinas and Caucasians. Breast Cancer Res Treat 158:113-126, 2016
36. Iyengar NM, Ghossein RA, Morris LG, et al: White adipose tissue inflammation and cancer-specific survival in patients with squamous cell carcinoma of the oral tongue. Cancer 10.1002/cncr.30251 [epub ahead of print on August 10, 2016]
37. Lonergan PE, Tindall DJ: Androgen receptor signaling in prostate cancer development and progression. J Carcinog 10:20, 2011
38. Subbaramaiah K, Morris PG, Zhou XK, et al: Increased levels of COX-2 and prostaglandin E2 contribute to elevated aromatase expression in inflamed breast tissue of obese women. Cancer Discov 2:356-365, 2012
39. Irahara N, Miyoshi Y, Taguchi T, et al: Quantitative analysis of aromatase mRNA expression derived from various promoters (I.4, I.3, PII and I.7) and its association with expression of TNF-alpha, IL-6 and COX-2 mRNAs in human breast cancer. Int J Cancer 118:1915-1921, 2006
40. Brown KA, McInnes KJ, Hunger NI, et al: Subcellular localization of cyclic AMP-responsive element binding protein-regulated transcription coactivator 2 provides a link between obesity and breast cancer in postmenopausal women. Cancer Res 69:5392-5399, 2009
41. Kawasaki N, Asada R, Saito A, et al: Obesityinduced endoplasmic reticulum stress causes chronic inflammation in adipose tissue. Sci Rep 2:799, 2012
42. Yang L, Calay ES, Fan J, et al: METABOLISM. S-Nitrosylation links obesity-associated inflammation to endoplasmic reticulum dysfunction. Science 349:500-506, 2015
43. Seo BR, Bhardwaj P, Choi S, et al: Obesitydependent changes in interstitial ECM mechanics promote breast tumorigenesis. Sci Transl Med 7:301ra130, 2015
44. Dirat B, Bochet L, Dabek M, et al: Cancerassociated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion. Cancer Res 71:2455-2465, 2011
45. Bochet L, Lehuédé C, Dauvillier S, et al: Adipocyte-derived fibroblasts promote tumor progression and contribute to the desmoplastic reaction in breast cancer. Cancer Res 73:5657-5668, 2013
46. Nieman KM, Kenny HA, Penicka CV, et al: Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med 17:1498-1503, 2011
47. Laurent V, Guérard A, Mazerolles C, et al: Periprostatic adipocytes act as a driving force for prostate cancer progression in obesity. Nat Commun 7:10230, 2016
48. Caesar R, Tremaroli V, Kovatcheva-Datchary P, et al: Crosstalk between gut microbiota and dietary lipids aggravates WAT inflammation through TLR signaling. Cell Metab 22:658-668, 2015
49. Rutkowski MR, Stephen TL, Svoronos N, et al: Microbially driven TLR5-dependent signaling governs distal malignant progression through tumorpromoting inflammation. Cancer Cell 27:27-40, 2015
50. Súarez-Zamorano N, Fabbiano S, Chevalier C, et al: Microbiota depletion promotes browning of white adipose tissue and reduces obesity. Nat Med 21:1497-1501, 2015
51. Cohen P, Spiegelman BM: Brown and beige fat: Molecular parts of a thermogenic machine. Diabetes 64:2346-2351, 2015
52. Pendyala S, Walker JM, Holt PR: A high-fat diet is associated with endotoxemia that originates from the gut. Gastroenterology 142:1100-1101.e2, 2012
53. Garrett WS: Cancer and the microbiota. Science 348:80-86, 2015
54. Visser M, Bouter LM, McQuillan GM, et al: Elevated C-reactive protein levels in overweight and obese adults. JAMA 282:2131-2135, 1999
55. Hursting SD, Digiovanni J, Dannenberg AJ, et al: Obesity, energy balance, and cancer: New opportunities for prevention. Cancer Prev Res (Phila) 5:1260-1272, 2012
56. Bachelot T, Ray-Coquard I, Menetrier-Caux C, et al: Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients. Br J Cancer 88:1721-1726, 2003
57. Sicking I, Edlund K, Wesbuer E, et al: Prognostic influence of pre-operative C-reactive protein in node-negative breast cancer patients. PLoS One 9:e111306, 2014
58. Allin KH, Bojesen SE, Nordestgaard BG: Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer. J Clin Oncol 27:2217-2224, 2009
59. Morris PG, Zhou XK, Milne GL, et al: Increased levels of urinary PGE-M, a biomarker of inflammation, occur in association with obesity, aging, and lung metastases in patients with breast cancer. Cancer Prev Res (Phila) 6:428-436, 2013
60. Kim S, Taylor JA, Milne GL, et al: Association between urinary prostaglandin E2 metabolite and breast cancer risk: A prospective, case-cohort study of postmenopausal women. Cancer Prev Res (Phila) 6:511-518, 2013
61. Goodwin PJ, Ennis M, Pritchard KI, et al: Fasting insulin and outcome in early-stage breast cancer: Results of a prospective cohort study. J Clin Oncol 20:42-51, 2002
62. Duggan C, Irwin ML, Xiao L, et al: Associations of insulin resistance and adiponectin with mortality in women with breast cancer. J Clin Oncol 29:32-39, 2011
63. Berrino F, Villarini A, Traina A, et al: Metabolic syndrome and breast cancer prognosis. Breast Cancer Res Treat 147:159-165, 2014
64. Barone BB, Yeh HC, Snyder CF, et al: Longterm all-cause mortality in cancer patients with preexisting diabetes mellitus: A systematic review and meta-analysis. JAMA 300:2754-2764, 2008
65. Erickson K, Patterson RE, Flatt SW, et al: Clinically defined type 2 diabetes mellitus and prognosis in early-stage breast cancer. J Clin Oncol 29:54-60, 2011
66. Creighton CJ, Sada YH, Zhang Y, et al: A gene transcription signature of obesity in breast cancer. Breast Cancer Res Treat 132:993-1000, 2012
67. Clément K, Viguerie N, Poitou C, et al: Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEB J 18:1657-1669, 2004
68. Cancello R, Henegar C, Viguerie N, et al: Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue ofmorbidly obese subjects after surgeryinduced weight loss. Diabetes 54:2277-2286, 2005
69. Adams TD, Stroup AM, Gress RE, et al: Cancer incidence and mortality after gastric bypass surgery. Obesity (Silver Spring) 17:796-802, 2009
70. SjöströmL: Reviewof the key results fromthe Swedish Obese Subjects (SOS) trial: A prospective controlled intervention study of bariatric surgery. J Intern Med 273:219-234, 2013